Drs. Peter Block and Kim Eagle discuss vitamin D and omega-3 fatty acid supplements in primary prevention (VITAL); low dose methotrexate for atherosclerotic event prevention (CIRT); CV risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT).

Keywords: AHA Annual Scientific Sessions, AHA18

< Back to Listings